MedBlog

Navigating pregnancy with a heart condition: What you need to know

Having a pre-existing heart condition can complicate pregnancy. Ashley Zink, M.D., discusses how specialized care helps women achieve positive outcomes.

Ashley Zink, M.D.

February 20, 2025

When is the right time for TAVR? Understanding your heart valve options

Is TAVR the best treatment for aortic stenosis? When is the best time to get a heart valve replacement? Learn more about your options.

Anthony Bavry, M.D.

February 10, 2025

Fighting heart failure with ‘Fantastic Four,’ new guidelines

New AHA guidelines highlight the benefits of SGLT2i medications for patients with heart failure and advances in diagnosing and treating ATTR amyloidosis.

Mark Drazner, M.D.

February 15, 2023

UT Southwestern ranked No. 1 hospital in DFW for sixth straight year

UT Southwestern has been ranked the No. 1 hospital in North Texas for the six years in a row, and ranked nationally for 9 specialties areas of health care.

July 26, 2022

Caregiver burden: Easing the physical and mental toll

Millions of adults who care for aging loved ones are at risk of burnout. UT Southwestern discusses closing the gaps between caregiving and geriatrics.

Namirah Jamshed, M.D.

May 23, 2022

Advances in cardiac imaging open big window into the heart

UT Southwestern explains how advanced heart imaging, such as cardiac CT and MRI, benefit patients.

Kartik Agusala, M.D.

March 29, 2022

How ‘diabetes drugs’ became valuable tools in treating heart failure

A surprise finding in SGLT2 inhibitor drug research has revealed a potentially groundbreaking heart failure treatment. Learn more from UT Southwestern.

Darren McGuire, M.D.

February 24, 2022

Study uncovers link between two key risk factors for first-time heart attack, stroke

New research from UT Southwestern shows a direct tie between high heart attack risk and dual diagnoses of coronary artery disease and high LP(a) cholesterol.

Parag Joshi, M.D.

February 23, 2022

Helping the heart heal itself: The science of regeneration

The concept of regenerating or growing heart tissue is not far-fetched. Ongoing research by UT Southwestern may potentially change the future of care for patients with mild to moderate heart disease.

February 16, 2022

Coffee can make the heart skip beats, but it brews up benefits, too

Coffee can make the heart skip a beat, but that might be OK. UT Southwestern discusses the findings from the CRAVE study on how coffee can affect heart health, sleep, and exercise.

Amit Khera, M.D.

January 13, 2022

TAVR is not the ‘beginning of the end’ for aortic stenosis open heart surgery

Two studies presented in March at #ACC19 are the talk of the cardiology community. Both address one question: Can low-risk patients with aortic stenosis benefit from TAVR? UT Southwestern says the data are intriguing, but the excitement is a bit premature. Learn more.

Dharam Kumbhani, M.D. / Anthony Bavry, M.D.

November 4, 2021

Warning signs when an artery is blocked, and how to fix it

UT Southwestern discusses how failure to diagnose and treat a Chronic Total Occlusion (CTO) can lead to symptoms and impact your quality of life.

Dharam Kumbhani, M.D.

December 3, 2020

Transradial angioplasty – a handy fix for blocked coronary arteries

Transradial angioplasty is a "handy" way to fix blocked heart arteries – by way of the wrist. It's safer than the standard approach for some patients. UT Southwestern discusses the benefits and the procedure. Learn more.

Dharam Kumbhani, M.D.

February 26, 2020

LVADs no longer just a bridge, but a long-term alternative to heart transplant

Left ventricular assist devices (LVAD) can help patients with advanced heart failure live longer and give them a better quality of life. UT Southwestern answers four common questions he gets from patients about LVADs.

February 12, 2020

MitraClip therapy: Which patients are ‘sick enough’?

MitraClip has emerged as a treatment option for patients with mitral valve disease who are not healthy enough for valve replacement surgery. However, the device is approved for only a small patient pool – and it might be unnecessary with optimized medical therapy.

Dharam Kumbhani, M.D.

February 20, 2019